Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive ...
Intel's stock is down after Lip-Bu Tan failed to offer quick fixes in a recent speech. But analysts saw positive aspects to his approach in the new role. Intel Corp. Chief Executive Lip-Bu Tan just ...
Tesla (TSLA) has always been a company that sparks both excitement and debate, and its recent challenges have only added fuel ...